Details for 2020165564

Up to date per 01.04.2026

Actions

Title / Product Name

PHARMAZEUTISCHE KOMBINATION VON EINEM TRIZYKLISCHEN BETA-LACTAMASE-HEMMER UND SPEZIFISCHE BETA-LACTAM ANTIOBIOTIKA

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2020165564

EP Publication Number

3698796

E-Number

1441718

Language

PCT Number

Publication Date

26.08.2020 A

27.10.2021 B1

Registration Date

27.10.2021

AT Publication Date

15.11.2021

Application Date

28.09.2017

Registration Number

Priorities

28.09.2016

201662401022 P

IPC

C07D 471/18 20060101AFI20210408BHEP

Maximum Duration of Protection

28.09.2037

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

CASAREZ, AnthonyNovartis Institutes for BioMedical Research Inc. 5300 Chiron Way Emeryville, CA 94608US

FUREGATI, MarkusNovartis Pharma AG Postfach 4002 BaselCH

KOCH, GuidoNovartis Pharma AG Postfach 4002 BaselCH

LIN, XiaodongNovartis Institutes for BioMedical Research, Inc. 5300 Chiron Way Emeryville, CA 94608US

OSSOLA, FlavioNovartis Pharma AG Postfach 4002 BaselCH

RECK, FolkertNovartis Institutes for BioMedical Research, Inc. 5300 Chiron Way Emeryville, CA 94608US

SIMMONS, Robert LowellNovartis Institutes for BioMedical Research, Inc. 5300 Chiron Way Emeryville, CA C94608US

ZHU, QingmingNovartis Institutes for BioMedical Research, Inc. 5300 Chiron Way Emeryville, CA 94608US